Introduction {#Sec1}
============

Penile cancer is relatively rare globally with an annual incidence of less than 1 case per 100,000 person-years (pyr) in Western countries \[[@CR1]\]. However, recorded incidences are higher in many countries in sub-Saharan Africa including Uganda (2.7/100,000 pyr), Swaziland (3.2/100,000 pyr) and Zimbabwe (1.6/100,000 pyr) \[[@CR2]--[@CR5]\]. Similarly, although penile cancer accounts for less than 0.5% of cancers in men globally, it accounts for a relatively higher proportion of cancers in Swaziland (4.4%), Rwanda (2.9%), Kenya (1.9%) and Uganda (1.7%) \[[@CR2], [@CR3], [@CR6]\].

Penile cancer typically occurs in later life (median age at diagnosis in the United States of America (USA) is 68 years) \[[@CR7]\]. Other factors associated with increased risk of penile cancer include low socio-economic status, cigarette smoking, human papillomavirus (HPV) infection, lack of penile hygiene, phimosis and penile inflammation \[[@CR8]\]. The first suggestion of a link between circumcision and penile cancer was in 1932, when, among 1,103 penile cancer cases in the USA, none were Jewish despite 3% of the population being Jewish (and hence circumcised) \[[@CR9]\]. Subsequent case series also showed a lower than expected prevalence of neonatal circumcision among penile cancer cases \[[@CR10]--[@CR12]\].

Ecological evidence came from studies in East Africa in the 1960s which showed that penile cancer was more common than expected in traditionally non-circumcising ethnic groups than among traditionally circumcising ethnic groups \[[@CR6], [@CR13]\]. The first case--control study of penile cancer, published in 1947 among American military personnel, showed that circumcision in childhood was rare among cases of penile cancer compared to controls (1.5% vs. 17.8%; OR = 0.07, 95% CI 0.01--0.28) \[[@CR14]\].

Although male circumcision is widely cited to protect against penile cancer \[[@CR15]--[@CR19]\], the epidemiological evidence has never been systematically evaluated. Circumcision services are currently being expanded for HIV prevention in several African countries \[[@CR20]\], and as penile cancer incidence is relatively high in many of these countries, expansion of circumcision services may provide an opportunity to reduce incidence of penile cancer.

The aim of this paper is to systematically review and summarise the epidemiological evidence of an association between male circumcision and penile intraepithelial neoplasia (PIN), in situ and invasive penile cancer, and to discuss the possible mechanisms and biological pathways for the association.

Materials and methods {#Sec2}
=====================

Search strategy {#Sec3}
---------------

Pubmed and Embase databases were searched on 22 April 2009 and updated on 15 September 2010 (for search terms see Box [1](#Tab1){ref-type="table"}). No language restrictions were imposed. We did not include circumcision in the search terms to avoid detection bias. We also searched reference lists of relevant papers. Where information was missing from published papers, we contacted authors to obtain relevant information.Box 1Search terms used in PubMed*Search 1*("Papillomavirus Infections/epidemiology"\[MeSH\] OR "Papillomavirus Infections/etiology"\[MeSH\] OR "Papillomavirus Infections/prevention and control"\[MeSH\] OR "Papillomavirus Infections/transmission"\[MeSH\] OR "Papillomaviridae"\[MeSH\] OR "Condylomata Acuminata/epidemiology"\[Mesh\] OR "Condylomata Acuminata/etiology"\[Mesh\] OR "Condylomata Acuminata/prevention and control"\[Mesh\] OR "Condylomata Acuminata/transmission"\[Mesh\] OR "Warts/epidemiology"\[Mesh\] OR "Warts/etiology"\[Mesh\] OR "Warts/prevention and control"\[Mesh\] OR "Warts/transmission"\[Mesh\]OR wart\*\[text word\] OR "papilloma virus"\[text\] OR "papilloma viruses"\[text word\] OR "HPV"\[text\] OR "condyloma acuminata"\[text word\] OR "condyloma acuminatum"\[text word\] OR papillomavir\*\[text word\] OR "Penile Neoplasms/epidemiology"\[Mesh\] OR "Penile Neoplasms/etiology"\[Mesh\] OR "Penile Neoplasms/prevention and control"\[Mesh\] OR "Penile Neoplasms/transmission"\[Mesh\] OR ((penil\*\[text\] OR penis\*\[text\]) AND (carcinoma\*\[text\] OR cancer\*\[text\] OR tumour \[text\] OR tumor \[text\] OR tumours\[text\] OR tumors\[text\] OR neoplas\*\[text\] OR "Bowen's disease"\[text\] OR "Bowen disease"\[text\])) OR "Bowenoid Papulosis"\[text\] OR *"Buschke-Lowenstein"\[text\] OR "Buschke Lowenstein"\[text\] OR "erythroplasia of Queyrat"\[text\]*) AND ("Genital Diseases, Male/epidemiology"\[Mesh\] OR "Genital Diseases, Male/etiology"\[Mesh\] OR "Genital Diseases, Male/transmission"\[Mesh\] OR "Genital Diseases, Male/prevention and control"\[Mesh\] OR "Penile Diseases"\[Mesh\] OR "Sexually Transmitted Diseases, Viral/epidemiology"\[Mesh\] OR "Sexually Transmitted Diseases, Viral/etiology"\[Mesh\] OR "Sexually Transmitted Diseases, Viral/prevention and control"\[Mesh\] OR "Sexually Transmitted Diseases, Viral/transmission"\[Mesh\] OR "Genitalia, Male"\[Mesh\] OR Genital\*\[Text\] OR penil\*\[text\] OR penis\*\[text\] OR scrot\*\[text\] OR anogenital\*\[text\] OR ano-genital\*\[text\] OR urethra\*\[text\] OR perine\*\[text\]) AND ("Epidemiologic Studies"\[MeSH\] OR "Risk Factors"\[MeSH\] OR "Odds Ratio"\[MeSH\] OR "Prevalence"\[MeSH\] OR "Incidence"\[MeSH\] OR "logistic models"\[MeSH\] OR "multivariate analysis"\[MeSH\] OR prevalence\[Text Word\] OR incidence\[Text Word\] OR "odds ratio"\[Text Word\] OR "risk ratio"\[Text Word\] OR "risk factor"\[Text Word\] OR "relative risk"\[Text Word\] OR rate\*\[text\]) AND ((Journal Article\[pt\] OR Letter\[pt\]) NOT "Case Reports" \[Publication Type\]) AND "Humans"\[MeSH Terms\] AND ("Male"\[MeSH\] OR Male \[Text\] OR Males\[Text\])*Search 2 (excluding articles from search 1)*("Papillomavirus Infections/epidemiology"\[MeSH\] OR "Condylomata Acuminata/epidemiology"\[Mesh\] OR "Warts/epidemiology"\[Mesh\] OR "Penile Neoplasms/epidemiology"\[Mesh\]) AND ("Genital Diseases, Male/epidemiology"\[Mesh\] OR "Genital Diseases, Male/etiology"\[Mesh\] OR "Genital Diseases, Male/transmission"\[Mesh\] OR "Genital Diseases, Male/prevention and control"\[Mesh\] OR "Penile Diseases"\[Mesh\] OR "Sexually Transmitted Diseases, Viral/epidemiology"\[Mesh\] OR "Sexually Transmitted Diseases, Viral/etiology"\[Mesh\] OR "Sexually Transmitted Diseases, Viral/prevention and control"\[Mesh\] OR "Sexually Transmitted Diseases, Viral/transmission"\[Mesh\] OR "Genitalia, Male"\[Mesh\] OR Genital\*\[Text\] OR penil\*\[text\] OR penis\*\[text\] OR scrot\*\[text\] OR anogenital\*\[text\] OR ano-genital\*\[text\] OR urethra\*\[text\] OR perine\*\[text\]) AND ((Journal Article\[pt\] OR Letter\[pt\]) NOT "Case Reports" \[Publication Type\]) AND "Humans"\[MeSH Terms\] AND ("Male"\[MeSH\] OR Male \[Text\] OR Males\[Text\])

All abstracts were reviewed independently by two authors (NL and HW). Epidemiological studies likely to contain information on risk factors for penile cancer were deemed potentially relevant. Agreement about potential relevance was reached by consensus, and full text copies of those papers were obtained.

Outcome definition {#Sec4}
------------------

Penile cancer included penile intra-epithelial neoplasia (PIN), in situ and invasive penile cancer. As in situ and invasive penile cancer may develop along different pathways \[[@CR21], [@CR22]\], and several studies have indicated that the effect of circumcision may vary depending on the stage of penile cancer \[[@CR23]--[@CR25]\], we decided a priori to analyse the effect of circumcision on (1) high-grade PIN and in situ penile cancer and (2) invasive penile cancer separately.

Data extraction {#Sec5}
---------------

Data were extracted independently by two authors (NL and HW) using a standardised pre-piloted data extraction form. Inconsistencies were discussed by both reviewers and consensus reached.

Study populations described in more than one paper were included only once, using data from the paper with most information on the study methods.

Methodological quality of included studies {#Sec6}
------------------------------------------

Seven quality domains were identified for case--control studies and six for cross-sectional studies (see supplementary material). We adopted an approach similar to that used by the Cochrane Collaboration for assessing risk of bias in randomised studies \[[@CR26]\] and studies were classified as having either a high, low, or an unclear (where data were not reported) risk of bias for each quality domain. Specific criteria for assessing risk of bias are included in the supplementary material; of note where 20% or more identified prevalent cases could not be contacted, studies were considered to be at high risk of length bias (survival bias). This can occur when prevalent cases are missing because they are too ill to participate or have died, so the included cases represent those with less aggressive/advanced disease. If the exposure (i.e. circumcision) has a differential effect on different stages of disease then length bias may be introduced.

Two authors (NL and HW) reviewed the quality of individual studies, and inconsistencies were discussed by both reviewers and consensus reached.

Data analysis {#Sec7}
-------------

The effect of circumcision on penile cancer was estimated using odds ratios (OR). Where ORs were not presented, crude ORs and 95% CI were calculated from the data when possible, using exact methods. For each study, the effect estimate was calculated as the adjusted estimate where present and the crude estimate otherwise. This best available estimate was included in a random effects meta-analysis, using Stata 11. The meta-analysis included (1) analyses of circumcised men compared to men *never* circumcised, and (2) analyses in which the temporality between circumcision procedure and cancer diagnosis were defined (assuming that circumcision before the age of 18 years preceded penile cancer).

Circumcision at older ages may have been in response to penile cancer or pre-cancerous conditions, and a priori defined subgroup analyses were conducted to compare the association by age at circumcision.

Phimosis is a condition occurring most commonly in young boys where the foreskin cannot be fully retracted over the glans and is a risk factor for penile cancer \[[@CR8], [@CR23], [@CR24], [@CR27], [@CR28]\]. Neonatal circumcision eliminates the risk of phimosis. Phimosis may be on the causal pathway between circumcision and penile cancer, so we defined a priori a subgroup analysis of the effect of circumcision on penile cancer among patients with no history of phimosis.

Summary estimates from sub-groups were formally compared using meta-regression. Heterogeneity was evaluated using the *I*^2^ statistic and the*P*-value for heterogeneity \[[@CR29]\]. The *I*^2^ statistic represents the percentage of between-study variation that is due to heterogeneity rather than chance.

To address methodological concerns, we planned sensitivity analyses, which restricted analyses to: (1) studies which adjusted for covariates and (2) studies which ascertained circumcision status by clinical exam. However, due to the small number of eligible studies identified, only the sensitivity analysis of adjusted analyses with invasive penile cancer as the outcome could be conducted. For studies where age at circumcision was not adequately reported, sensitivity analyses were performed including them in meta-analyses of the most likely age at circumcision, based on information in the paper concerning the age at circumcision among cases or previously published data.

Results {#Sec8}
=======

Results of search strategy {#Sec9}
--------------------------

A total of 3,366 papers were identified from the database searches and the full text was obtained for 306 of these (Fig. [1](#Fig1){ref-type="fig"}). A total of 269 papers were excluded based on the full text, including two studies that compared the prevalence of circumcision among cases of invasive penile carcinoma with cases of in situ penile cancer. An additional six papers were identified from references and review papers. Eight eligible papers were identified which included information on penile cancer.Fig. 1Flow chart of study selection for inclusion in the systematic review. ^§^3 papers evaluated the effect of circumcision on both in situ and invasive penile cancer. ^†^The search was conducted as part of a wider search strategy to identify papers on the association of male circumcision with HPV, genital warts and penile cancer

Description of eligible papers {#Sec10}
------------------------------

The eight papers evaluating the effect of circumcision on penile cancer included one cross-sectional study and seven case--control studies (Table [1](#Tab2){ref-type="table"}). Study populations were from Europe (*n* = 4), the United States (*n* = 3), and China (*n* = 1).Table 1Summary of studies of the association of male circumcision and penile cancerFirst authorCountry, yearStudy designStudy PopulationNo. casesNo. controls% Circumcised^a^Age at circumcisionExposure comparison groupBest estimate OR (95% CI)^b^High-grade PIN or In situ CarcinomaInvasive Carcinoma*Circumcised in childhood/adolescence (≤18 years of age)* Schrek \[[@CR14]\]USA, Cases diagnosed 1931--1945Case controlPatients at veterans hospital133 invasive23618\<17 yearsIndividuals never circumcisedN/A0.07 (0.01, 0.28) Madsen \[[@CR28]\]Denmark, Cases diagnosed 1979--1998Case controlGeneral^c^18 in situ; 53 invasive1034\<18 yearsNever circumcised and those circumcised ≥ 18 years0.00 (0.00, 5.96)^d^0.00 (0.00, 1.84)^d^ Tseng \[[@CR24]\]USA, 1983--1986Matched case controlGeneral43 in situ; 40 invasive8744\<1 yearIndividuals never circumcised1.0 (0.41, 2.6)^e^0.41 (0.13, 1.1)^e^ Daling \[[@CR23]\]USA, cases diagnosed 1979--1998Case control (frequency matched)General71 in situ; 53 invasive63961\<10 yearsIndividuals never circumcised0.91 (0.5, 1.43)^f^0.53 (0.28, 1.00)^f^*Circumcised mostly as adults (median age ≥ 18 years; minimum 10 years old)* Schrek \[[@CR14]\]USA, Cases diagnosed 1931--1945Case controlPatients at veterans hospital^g^136 invasive2013≥18 yearsIndividuals never circumcisedN/A1.27 (0.34, 4.52) Brinton \[[@CR27]\]China, 1984--1988Matched case control^h^General128 invasive1400.7Circumcised \> 5 years prior to the study^i^Individuals never circumcisedN/A14.87 (1.80, 121.0)^j^ Daling \[[@CR23]\]USA, cases diagnosed 1979--1998Case control (frequency matched)General32 in situ; 39 invasive2785≥10 years^k^Individuals never circumcised0.53 (0.06, 2.28)2.39 (0.91, 5.78)*Age at circumcision not reported* Tseng \[[@CR24]\]USA, 1983--1986Matched case controlGeneral34 in situ; 44 invasive6221≥1 year^l^Individuals never circumcised0.81 (0.22, 3.00)^e^0.91 (0.31, 4.1)^e^ Aynaud \[[@CR30]\]France, 1991--1992Cross sectionalMale partners of women with genital condyloma or intraepithelial neoplasia92 PIN I, II & III908^m^26Not reportedIndividuals never circumcised0.56 (0.30, 1.00)N/A Mallon \[[@CR32]\]UK, 1994--1997Case controlDermatology clinic attendees4 SCC^n^30548Not reported^o^Individuals never circumcisedN/A0.40 (0.04--4.35)^p^ Porter \[[@CR31]\]UK, 1994--2001Case controlDermatology clinic attendees35 PIN^q^30548Not reported^r^Individuals never circumcised0.27 (0.10, 0.66)N/A*OR* Odds ratio^a^Prevalence of circumcision among controls for case control studies; prevalence of circumcision among whole study population for cross-sectional studies; age-specific circumcision prevalence presented throughout^b^Adjusted estimate presented where available; crude estimate presented otherwise^c^Population controls only included; prostrate cancer controls excluded^d^Not included in the meta-analysis, since exposure comparison group may include men circumcised at older ages^e^Adjusted for age, education and income, phimosis, injury to the penis, genital/rectal warts, infection/inflammation/itching of skin of the penis, cigarette smoking, regular moderate or heavy physical activity^f^Adjusted for age, cigarette smoking and number of sex partners^g^Includes all ethnic groups. (Clinical group \[*n* = 139\] and control groups D and E)^h^Cases ascertained both prospectively and retrospectively^i^None were circumcised at birth and all were circumcised for medical indications (excessive foreskin, tightness, inflammation, itching and pain). Mean age of participants 55 years (range 20--79)^j^Adjusted for age, education, sexual relations outside of marriage, prior genital condition^k^Of those circumcised over 10 years old, the median age at circumcision was 41 years for cases and 18 years for controls^l^Median age at circumcision could not be determined from this group^m^Non-cases (subjects without PIN I, PIN II or PIN III)^n^Squamous cell carcinoma^o^The circumcised case was circumcised at 3 years old. No information on the age at circumcision for the 146 circumcised controls^p^Adjusted for age^q^Cases included patients with PIN (Bowenoid papulosis, Erythroplasia of Queryat and Bowens disease)^r^One circumcised patient with Bowen disease known to be circumcised aged 2 years (reported in \[[@CR32]\]). No information on age at circumcision for remaining 6 circumcised cases or 146 circumcised controls

Age at circumcision was categorised into three groups: childhood/adolescence (all participants \< 18 years); mostly adults (median age ≥ 18 years; minimum 10 years old); and age inadequately reported (Table [1](#Tab2){ref-type="table"}). The proportion of men circumcised during childhood/adolescence ranged from 4% in Denmark \[[@CR28]\] to 61% in the United States \[[@CR23]\]. Circumcision among adults ranged from 0.7% in China \[[@CR27]\] to 5% in the USA \[[@CR23]\].

Five papers evaluated the effect of circumcision on PIN and/or in situ cancer \[[@CR23], [@CR24], [@CR28], [@CR30], [@CR31]\] and six papers evaluated the effect on invasive cancer \[[@CR14], [@CR23], [@CR24], [@CR27], [@CR28], [@CR32]\] (Fig. [1](#Fig1){ref-type="fig"}; Table [1](#Tab2){ref-type="table"}).

Quality of studies {#Sec11}
------------------

One study had five quality domains classified as low risk and two domains classified as unclear risk \[[@CR27]\]; all other studies had a high risk of bias in one or more of the quality domains (Table [2](#Tab3){ref-type="table"}).Table 2Quality of included studiesFirst authorCase definitionCase identificationParticipation^a^Selection of controlsAscertainment of circumcision status and age at circumcisionBlindingAdjustment/matching*A. Case control studies*Brinton \[[@CR27]\]Hospital cases. All cases were pathologically confirmed by one pathologist^b^\
*Low risk*Incident^c^ (45%) and prevalent (55%) cases. 93% of cases successfully contacted\
*Low risk*Cases: 90% agreed to participate; 7% died; 0.5% refused to participate; 2% had communication problems; 0.5% miscellaneous reasons\
Controls: 96% agreed to participate; 1% died; 0.5% had communication problems; 0.5% were unwell; 2% miscellaneous reasons\
*Low risk*Population controls randomly selected from a list of all men resident within the same area as cases\
*Low risk*Clinical exam^d^ or self report^e^. Participants circumcised \>5 years prior to the study^f^\
*Unclear risk*Not stated\
*Unclear risk*Individually matched on age at diagnosis and residence\
Adjusted for age, education, sexual relations outside of marriage, prior genital condition\
*Low risk*Daling \[[@CR23]\]Population cases identified through Cancer Surveillance System. Cancer stage defined (in situ or invasive)\
*Low risk*All prevalent cases. 71% of cases successfully contacted\
*High risk*Cases: 55% agreed to participate; 13% died; 9% physician refused permission to contact; 7% emigrated; 16% refused to participate\
Controls: 71% agreed to participate; Reasons for non-participation not given\
*High risk*Population controls identified through random digit dialling within the counties cases were taken from\
*Low risk*Self-report\
Age at circumcision given\
*Low risk*No blinding of interviewers or study participants\
*High risk*Frequency matched on age, residence and year of diagnosis\
Adjusted for age, cigarette smoking, number of sexual partners\
*Low risk*Madsen \[[@CR28]\]Population cases identified through the Cancer & Pathology Registries and pathology department files\
Cancer stage defined (in situ or invasive)\
*Low risk*All prevalent cases. 47% of cases successfully contacted\
*High risk*Cases: 27% agreed to participate; 38% died or unwell; 18% received no reply from hospital or practitioner; 1% emigrated; 5% had no telephone; 11% miscellaneous reasons\
Controls: 60% agreed to participate; 7% died; 6% had no telephone; 27% miscellaneous reasons\
*High risk*Population controls identified through civil registration system\
*Low risk*Self-report. Age at circumcision given\
*Low risk*Interviewers blinded and unaware of the study hypotheses\
*Low risk*Frequency matched on year of birth\
*Low risk*Mallon \[[@CR32]\]Hospital cases identified through a penile dermatoses clinic. Cancer stage defined (invasive)\
*Low risk*All incident cases\
*Low risk*Cases: No information given\
Controls: No information given\
*Unclear risk*Hospital controls: men without genital skin disease attending general dermatology clinic\
*Unclear risk*Clinical Exam at time of diagnoses\
Age at circumcision incompletely reported\
*High risk*No blinding\
*Low risk*Adjusted for age\
*Low risk*Porter \[[@CR31]\]Hospital cases identified through a penile dermatoses clinic. Cancer stage defined (invasive)\
*Low risk*All incident cases\
*Low risk*Cases: No information given\
Controls: No information given\
*Unclear risk*Hospital controls: men without genital skin disease attending general dermatology clinic\
*Unclear risk*Clinical Exam at time of diagnoses\
Age at circumcision incompletely reported\
*High risk*No blinding\
*Low risk*No matching or adjustment\
*High risk*Schrek \[[@CR14]\]Hospital cases identified at a veterans hospital\
*Low risk*All prevalent cases. The majority of cases were referrals^g^\
*High risk*Cases: No information given\
Controls: No information given\
*Unclear risk*Patients with tumour admitted to clinic in 1944\
*Low risk*Self-reported\
Age at circumcision reported\
*Low risk*No information given\
*Unclear risk*No matching or adjustment\
*High risk*Tseng \[[@CR24]\]Population cases identified through Cancer Surveillance Programme. Cancer stage defined (in situ or invasive)\
*Low risk*Incident and prevalent cases^h^\
71% of cases successfully contacted\
*High risk*Cases: 50% agreed to participate; 17% died; 6% had emigrated; 11% physician refused permission to contact; 21% refused to participate\
Controls: 100 controls selected based on 100 cases who agreed to participate. The first eligible match was interviewed for 71 cases; the 2nd eligible match was interviewed for a further 18 cases\
*High risk*Neighbourhood controls identified using algorithm that used index case as reference point\
*Low risk*Self-report\
Age category at circumcision given. No information on median age among older age group (\>10 years)\
*Unclear risk*The study hypothesis was not discussed with participants, but interviewers were not blinded\
*High risk*Individually matched on ethnicity, date of birth\
Adjusted for age, education, income\
*Low risk*First authorOutcome definitionSources of participantsParticipationAscertainment of circumcision statusBlindingAdjustment/matching*B. Cross*-*sectional study*Aynaud \[[@CR30]\]Prevalent cases. PIN defined on clinical and histological grounds\
*Low risk*Male partners of women with genital condyloma or intraepithelial neoplasia\
*Unclear risk*No information on refusals\
*Unclear risk*Clinical exam, age not given\
*High risk*Not given\
*Unclear risk*No matching or adjustment\
*High risk*^a^Proportion of all cases/controls identified who agreed to participate^b^First 25 prospective cases confirmed by 2nd pathologist^c^61% of incident cases were interviewed within 1 month of diagnosis^d^Incident cases and their matched controls^e^Prevalent cases and their matched controls^f^The specific age at circumcision was not given. Mean age of subjects at time of study was 55 years^g^The majority of cases had first been treated by a private practitioner and presented at hospital an average of 21 months after onset of lesion. Equivalent information was not presented for controls^h^Incident cases identified prospectively over 36 months and prevalent cases identified retrospectively over 84 months

The potential for length bias was considered to be high for three case--control studies, where prevalent cases were identified and ≥20% could not be contacted for an interview \[[@CR23], [@CR24], [@CR28]\] and unclear in one other study \[[@CR14]\] (Table [2](#Tab3){ref-type="table"}). For these studies, the proportion that were known to have died between diagnosis and the time of the study was 13% \[[@CR23]\], 17% \[[@CR24]\] and 34--38% \[[@CR28]\].

The risk of bias from poor participation was low for only one study \[[@CR27]\] (Table [2](#Tab3){ref-type="table"}). Fewer than 80% of identified subjects agreed to participate for three studies \[[@CR23], [@CR24], [@CR28]\] and for one of these, the proportion that agreed to participate was substantially higher for controls (60%) compared to cases (27%) \[[@CR28]\]. Information on participation was not available in three studies \[[@CR30]--[@CR32]\].

In four studies, the age at circumcision was not reported or incompletely reported, \[[@CR24], [@CR30]--[@CR32]\] and the temporality of any observed association between circumcision and penile cancer could not be assessed. In a fifth study \[[@CR27]\], although the exact age at circumcision was not reported, the authors report that none of the boys were circumcised at birth and all participants were circumcised more than 5 years prior to the study. A high risk of confounding was present in three studies that did not adjust for age in either the study design or analysis \[[@CR14], [@CR30], [@CR31]\].

Association between circumcision and penile cancer {#Sec12}
--------------------------------------------------

### Penile intra-epithelial neoplasia and in situ penile Cancer {#Sec13}

Seven analyses evaluated the association of circumcision on PIN and in situ penile cancer \[[@CR23], [@CR24], [@CR28], [@CR30], [@CR31]\] (Table [1](#Tab2){ref-type="table"}; Fig. [1](#Fig1){ref-type="fig"}).

One of the three analyses of circumcision in childhood/adolescence and PIN or in situ penile cancer compared men circumcised in childhood/adolescence with men not circumcised in childhood/adolescence \[[@CR28]\] and was thus excluded from the meta-analysis. In this study, there were no penile cancer cases among men circumcised in childhood/adolescence, but the 95% CI was wide (OR = 0.00, 95% CI 0.00--5.96). The remaining two analyses were deemed at low risk of bias from confounding in our quality assessment. These showed little evidence of an association of circumcision with PIN and in situ penile cancer (summary OR = 0.93, 95% CI 0.59--1.47; *p*-heterogeneity = 0.86; *I*^2^ = 0.0%) (Fig. [2](#Fig2){ref-type="fig"}). The OR from the single analysis among men circumcised mostly as adults was smaller (OR = 0.53; 95% CI 0.06--2.28) but confidence intervals were wide, and there was little evidence of a difference in this effect estimate and the summary estimate for those circumcised in childhood/adolescence (*p* = 0.60).Fig. 2Association of male circumcision and PIN (I--III) or in situ penile carcinoma: random effects meta-analysis

Three analyses did not adequately report age at circumcision. For one (a cross-sectional study from France), circumcision was likely to have occurred in childhood and this showed some evidence of a protective effect of circumcision on PIN and in situ penile cancer (OR = 0.56; 95% CI 0.30--1.00) \[[@CR30]\]. A sensitivity analysis including this analysis with the other analyses of childhood/adolescent circumcision provided only weak evidence of a protective effect on PIN/in situ penile cancer (summary OR = 0.77; 95% CI 0.54--1.11 *p*-heterogeneity = 0.42; *I*^2^ = 0.0%; *n* = 3).

### Invasive penile cancer {#Sec14}

Nine analyses from six papers evaluated the effect of circumcision on invasive penile cancer \[[@CR14], [@CR23], [@CR24], [@CR27], [@CR28], [@CR32]\]; (Table [1](#Tab2){ref-type="table"}; Fig. [1](#Fig1){ref-type="fig"}). Three of the four analyses of circumcision in childhood/adolescence, used a comparison group of never circumcised men. The overall OR from these three analyses showed strong evidence of a protective effect (summary OR = 0.33; 95% CI 0.13--0.83) (Fig. [3](#Fig3){ref-type="fig"}). There was some evidence of heterogeneity in estimates (*p*-heterogeneity = 0.11; *I*^2^ = 55%) although all three studies showed a protective rather than detrimental effect. The sensitivity analysis including only the two analyses that adjusted for covariates showed little evidence of heterogeneity (summary OR = 0.50; 95% CI 0.29--0.86; *p*-heterogeneity = 0.69; *I*^2^ = 0.0%; *n* = 2).Fig. 3Association of male circumcision and invasive penile carcinoma: random effects meta-analysis

The relationship was reversed for analyses of men circumcised mostly as adults (summary OR = 2.71; 95% CI 0.93--7.94; *p*-heterogeneity = 0.15; *I*^2^ = 48%; 3 analyses).

Two analyses inadequately reported the age at circumcision and neither provided evidence of a protective effect of circumcision on invasive cancer (Table [1](#Tab2){ref-type="table"}; Fig. [3](#Fig3){ref-type="fig"}). In one of these analyses, from a case--control study from the UK, the one cancer patient who was circumcised had been circumcised in childhood, and the controls are also likely to have been circumcised during childhood \[[@CR32]\]. Including this analysis in the summary estimate for childhood/adolescent circumcisions gave similar results (summary OR = 0.36; 95% CI 0.17--0.75; *n* = 4) to the overall summary at these ages (OR = 0.33; 95% CI 0.13--0.83; *n* = 3) with less heterogeneity in estimates (*p*-heterogeneity = 0.22; *I*^2^ = 32% vs. *p*-heterogeneity = 0.11; *I*^2^ = 55%).

For the two analyses \[[@CR23], [@CR24]\] which assessed the effect of childhood/adolescent circumcision on both in situ and invasive penile cancer, there was a stronger association with invasive disease (OR 0.53 vs. 0.91 in the Daling et al. \[[@CR23]\] paper and 0.41 vs. 1.0 in the Tseng et al. \[[@CR24]\] paper) (Table [1](#Tab2){ref-type="table"}). However, a meta-regression of the five analyses evaluating the effect of childhood/adolescent circumcision compared to no circumcision revealed weak evidence that the effect differed for in situ and invasive penile cancer (*p* = 0.20), although power for this analysis was low \[[@CR14], [@CR23], [@CR24]\].

### The role of phimosis in the association between circumcision and penile cancer {#Sec15}

To examine the association of circumcision with penile cancer beyond the effect mediated through phimosis, two papers stratified analyses by history of phimosis \[[@CR23], [@CR24]\]. Both of these found an association of circumcision with invasive penile cancer among all subjects, but no evidence of an association among those with no history of phimosis (Table [3](#Tab4){ref-type="table"}).Table 3Effect of circumcision on invasive penile cancer by history of phimosisFirst authorStudy designAge at circumcisionComparison groupAdjusted OR (95% CI)All subjectsSubjects with no history of phimosisDaling \[[@CR23]\]Case control\<10 yearsNot circumcised in childhood^a^0.43 (0.24, 0.77)2.0 (0.59, 10.0)^b^Tseng \[[@CR24]\]Matched case control\<1 yearNever circumcised0.41 (0.13, 1.1)0.79 (0.29, 2.6)^ca^Not circumcised in childhood (\<10 years old) but those circumcised later in life are included^b^A history of phimosis was only reported among those not circumcised in childhood (≥10 years); among these children 254/278 controls had no history of phimosis and 20/39 cases of invasive cancer had no history of phimosis. Specific information on the numbers included in this analysis was not stated in the paper^c^The analysis among those with no history of phimosis comprised all 44 participants who were circumcised at \<1 year old and 61/83 of the uncircumcised participants

Discussion {#Sec16}
==========

Circumcision in childhood/adolescence was protective against invasive penile cancer, with a summary odds ratio of 0.33 (95% CI 0.13--0.83). Although there was some evidence of heterogeneity (*p* = 0.11, *I*^2^ = 55%), all three studies demonstrated a protective effect (ORs 0.07, 0.41 and 0.53, respectively). In contrast, there was some evidence that the risk of invasive penile cancer was elevated among men circumcised mostly as adults. There was little evidence of an association of circumcision at any age with PIN or in situ penile cancer.

Quality of studies {#Sec17}
------------------

The overall risk of bias across studies was high, with only one study classified with no quality domains at high risk of bias \[[@CR27]\]. Only two studies were confined to incident cases due to the rarity of penile cancer and in the studies which included at least some prevalent cases, risk of length (survival) bias was considered to be high. It is possible that the effect of circumcision may be different in the excluded cases; the effect of circumcision appears to be greater on invasive compared to PIN/in situ penile cancer and thus studies including prevalent cases could underestimate the true effect of circumcision on penile cancer. Specifically in analyses of childhood/adolescent circumcision and invasive cancer, all three included studies had a high risk of length bias. It is therefore possible that the summary odds ratio is an underestimate of the true effect.

Given the difficulties of conducting studies on penile cancer, the following could be considered in future studies to limit potential biases. Considering the rarity of penile cancer, multi-centre international case--control studies are the most feasible study design. However, prospectively ascertaining incident penile cancer cases to enrol in case--control studies will be the most effective method to limit length bias and could help to increase participation. Circumcision status should ideally be confirmed by a clinician. Finally, age at circumcision must be collected to allow the temporality between circumcision and penile cancer to be ascertained.

Effect of circumcision on in situ versus invasive penile cancer {#Sec18}
---------------------------------------------------------------

Circumcision had a protective association with invasive penile cancer but there was no evidence of an effect on PIN/in situ. Two additional papers compared the prevalence of circumcision among cases of invasive penile cancer compared to in situ cancer \[[@CR25], [@CR33]\]. In one, the OR for invasive penile cancer (compared to in situ cancer) was 0.15 among men circumcised as newborns compared to uncircumcised men (95% CI 0.02--0.66) \[[@CR25]\]. In the second paper, none of the eight cases of invasive penile cancer were circumcised neonatally, whereas 46% of those cases with PIN or in situ penile cancer were circumcised neonatally; all eight cases (100%) of invasive penile cancer were circumcised as adults and 8% of in situ cases were circumcised as adults \[[@CR33]\].

There is evidence that some in situ cancers develop along a different pathway compared to invasive cancers \[[@CR21], [@CR22]\]. PIN/in situ penile cancer is a diverse group of neoplasms ranging from the benign form of Bowenoid papulosis to the more aggressive forms of Bowen's disease and erythroplasia of Queyrat \[[@CR34]\] and these may have differing potential to progress to invasive disease \[[@CR35]\]. Similar observations have been made for vulvar cancer where two distinct aetiologic pathways have been described for basaloid/warty tumour and keratinizing tumours \[[@CR36]\]. In one study, a strong effect was observed on erythroplasia of Queyrat (OR = 0.12, 95% CI 0.00--0.90, *n* = 315) and Bowenoid papulosis cases (OR = 0.20, 95% CI 0.04--0.69), although there was no evidence of an effect on Bowen's disease (OR = 0.54, 95% CI 0.01--10.58, *n* = 308) \[[@CR31]\]. Considering the possibility of different developmental pathways for penile cancer, it is biologically plausible that circumcision has a different effect on specific aetiological subtypes.

Circumcision may also lead to increased detection of early stage penile cancers, for example if such tumours tend to be located under the foreskin. This increased ascertainment in circumcised men would mask a true underlying effect of circumcision on PIN/in situ penile cancer and may therefore explain the lack of effect on PIN/in situ penile cancer observed in this review. Many penile tumours occur on the foreskin, and circumcision may exert an effect partially by removing a site susceptible to development of tumours.

Circumcision and phimosis {#Sec19}
-------------------------

Phimosis is one of the strongest risk factors for penile cancer and four papers evaluated the association between phimosis and penile cancer (OR range 4.9--37.2 \[[@CR23], [@CR24], [@CR27], [@CR28]\]). The effect of childhood/adolescent circumcision on invasive penile cancer may be largely mediated through elimination of phimosis, since there was no evidence of an association of circumcision with invasive disease when analyses were restricted to individuals with no history of phimosis \[[@CR23], [@CR24]\]. These results should be interpreted cautiously; they were secondary analyses among a sub-sample of the study populations and it is possible that they were underpowered. However, this is biologically plausible as circumcision eliminates risk of phimosis, and phimosis is likely to lead a build up of smegma and repeated inflammations, which may in turn lead to an increased risk of penile cancer \[[@CR17]\]. Phimosis is a stronger risk factor for invasive disease compared to in situ cancer \[[@CR23], [@CR24]\] which further supports the argument that circumcision acts through prevention of phimosis and that some in situ cancers develop through a different pathway to invasive cancer.

Circumcision in adulthood {#Sec20}
-------------------------

One possible reason for the increased risk of invasive penile cancer among men circumcised mostly as adults may be reverse causality: the surgery may have been performed as a treatment for penile cancer, a cancer precursor, or to treat an underlying medical condition known to be a risk factor for penile cancer (foreskin tightness, phimosis, or inflammation of the foreskin). Indeed in one study, all identified circumcisions were performed at older ages due to a medical indication, and although these were performed \>5 years prior to the reference date \[[@CR27]\], this may explain the significantly elevated risk for invasive cancer among circumcised men (OR = 14.87).

Circumcision and penile HPV infection {#Sec21}
-------------------------------------

Unlike cervical cancer, evidence suggests that HPV infection is not a necessary cause of penile cancer, with HPV prevalence ranging between 15 and 71% among penile cancer cases \[[@CR21]\]. One paper measured HPV DNA in tumour tissue \[[@CR23]\] and there was some suggestion of a greater protective association of childhood/adolescent circumcision with HPV negative tumours than HPV positive tumours although the CIs around these estimates were wide and overlapping (OR = 0.48, 95% CI 0.17--1.43 vs. OR = 0.83, 95% CI 0.45--1.43). This association may be due to chance, and contrasts with evidence from systematic reviews \[[@CR37]\] which showed circumcision is protective against HPV prevalence, and perhaps also against persistent \[[@CR38]\] HPV infection in men. However, it may also reflect that HPV is more commonly associated with in situ tumours than invasive tumours \[[@CR23]\], and the greater effect of circumcision on invasive rather than in situ tumours. An alternative explanation, is that HPV--PCR is compromised in penile cancer samples taken at later stages of disease due to tissue necrosis, and invasive penile cancer is in fact HPV-associated \[[@CR39]\].

Potential impact in the scale up of circumcision services {#Sec22}
---------------------------------------------------------

In the two studies in the USA that calculated an adjusted OR, assuming that childhood/adolescent circumcision is causally related to invasive penile cancer, the population attributable fractions were 27% \[[@CR23]\] and 50% \[[@CR24]\], suggesting that a considerable proportion of cases were due to a lack of circumcision in these populations. Circumcision prevalence is relatively high in the United States and it is quite likely a greater proportion of cases could be averted in countries with a lower prevalence of circumcision. For example in Swaziland, where circumcision is not commonly practised and penile cancer incidence is comparatively high (3.2 cases per 100,000 pyr \[[@CR2], [@CR3]\]), a national strategy exists to increase circumcision prevalence to 80% among HIV negative males aged 15--24 and to 33% among male neonates as part of an HIV prevention strategy \[[@CR40]\]. Successful implementation of this strategy may therefore lead to a considerable reduction in the incidence of penile cancer as well as HIV.

Conclusions {#Sec23}
-----------

These data suggest that childhood/adolescent circumcision is protective against invasive penile cancer. This effect could be mediated partly through an effect on phimosis. Circumcision services among adults are currently being expanded as an HIV prevention strategy \[[@CR20]\] and neonatal/infant circumcision is emerging as a cost-effective long-term HIV prevention strategy \[[@CR41]\]. Some countries in sub-Saharan Africa experience considerably higher incidence of penile cancer compared to Western countries and expansion of circumcision services in this region provides an opportunity to reduce penile cancer as well as HIV in men.
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